Mesenchymal stem cells can modulate longitudinal changes in cortical thickness and its related cognitive decline in patients with multiple system atrophy

Multiple system atrophy (MSA) is an adult-onset, sporadic neurodegenerative disease. Because the prognosis of MSA is fatal, neuroprotective or regenerative strategies may be invaluable in MSA treatment. Previously, we obtained clinical and imaging evidence that mesenchymal stem cell (MSC) treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Sunwoo, Mun Kyung, Yun, Hyuk Jin, Song, Sook K., Ham, Ji Hyun, Hong, Jin Yong, Lee, Ji E., Lee, Hye S., Sohn, Young H., Lee, Jong-Min, Lee, Phil Hyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056280/
https://www.ncbi.nlm.nih.gov/pubmed/24982631
http://dx.doi.org/10.3389/fnagi.2014.00118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056280/
https://www.ncbi.nlm.nih.gov/pubmed/24982631
http://dx.doi.org/10.3389/fnagi.2014.00118

Ejemplares similares